Skip to main content

Daptomycin Etest MICs for methicillin-resistant Staphylococcus aureus vary among different media

Abstract

For optimum activity of daptomycin (DAP) in vitro, medium supplemented with calcium ions at physiological concentration (i.e., 50 mg/l) is required for determination of DAP minimum inhibitory concentration (MIC) in the Clinical and Laboratory Standards Institute (CLSI) broth microdilution (BMD) method. However, our literature review found that Mueller–Hinton agar (MHA) brands used for the DAP Etest had different calcium ion (Ca2+) concentrations among the reports. For 98 clinical methicillin-resistant Staphylococcus aureus isolates previously unexposed to DAP, MICs were assessed by use of the Etest with MHA plates with different media (MHA-A, MHA-B, and MHA-C) and compared with those from the CLSI reference BMD method. The instructions for the Etest recommend MHA with Ca2+ of 25–40 mg/l for DAP MIC testing; Ca2+ concentrations for each type of MHA were 20.4 mg/l in MHA-A, 45.2 mg/l in MHA-B, and 52.0 mg/l in MHA-C. When the MIC50/MIC90 of the clinical isolates were studied, the Etest MICs for MHA-A were 1-fold dilution higher than for the BMD value. In contrast, for MHA-B they were 1-fold dilution lower, and for MHA-C MIC50 was 1.5-fold dilution lower and MIC90 was 2-fold dilution lower. MICs measured in MHA with higher Ca2+ tended to be lower. Comparison of MICs between BMD and the Etest for each MHA showed they were significantly different (p < 0.0001). The correlation coefficient was 0.6258 (p < 0.0001) for MHA-A, 0.4224 (p < 0.0001) for MHA-B, and 0.2504 (p = 0.0129) for MHA-C. Our results suggest there are differences in DAP MICs between MIC testing methods and differences between Ca2+ concentrations in MHA. For more objective and accurate measurement of DAP MICs, there should be discussion about standardization of Ca2+ in MHA.

This is a preview of subscription content, access via your institution.

References

  1. Koeth LM, Thorne GM. Daptomycin in vitro susceptibility methodology: a review of methods, including determination of calcium in testing media. Clin Microbiol News. 2010;32:161–9.

    Article  Google Scholar 

  2. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 8th ed. Document M07-A8. Wayne, PA: CLSI; 2009.

  3. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Twentieth informational supplement. Document M100-S20. Wayne, PA: CLSI; 2010.

  4. Koeth LM, DiFranco JM. Comparison of daptomycin Etest MICs on Mueller Hinton, IsoSensitest and brain heart infusion agars from Europe against 20 Staphylococcus aureus isolates. Eur J Clin Microbiol Infect Dis. 2010;29:1261–4.

    PubMed  Article  CAS  Google Scholar 

  5. Hanberger H, Nilsson LE, Maller R, Isaksson B. Pharmacodynamics of daptomycin and vancomycin on Enterococcus faecalis and Staphylococcus aureus demonstrated by studies of initial killing and postantibiotic effect and influence of Ca2+ and albumin on these drugs. Antimicrob Agents Chemother. 1991;35:1710–6.

    PubMed  Article  CAS  Google Scholar 

  6. Sader HS, Moet GJ, Farrell DJ, Jones RN. Antimicrobial susceptibility of daptomycin and comparator agents tested against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: trend analysis of a 6-year period in US medical centers (2005–2010). Diag Microbiol Infect Dis. 2011;70:412–6.

    Article  CAS  Google Scholar 

  7. Sader HS, Farrell DJ, Jones RN. Antimicrobial activity of daptomycin tested against gram-positive strains collected in European hospitals: results from 7 years of resistance surveillance (2003–2009). J Chemother. 2011;23:200–6.

    PubMed  CAS  Google Scholar 

  8. Kelley PG, Gao W, Ward PB, Howden BP. Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure. J Antimicrob Chemother. 2011;66:1057–60.

    PubMed  Article  CAS  Google Scholar 

  9. Panagea T, Galani I, Souli M, Karantani I, Giamarellou H, Petrikkos G. Glycopeptide and daptomycin susceptibility and vancomycin heteroresistance of methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates from a Greek university hospital. Int J Antimicrob Agents. 2011;38:451–2.

    PubMed  Article  CAS  Google Scholar 

  10. Jevitt LA, Thorne GM, Traczewski MM, Jones RN, McGowan JE Jr, Tenover FC, et al. Multicenter evaluation of the Etest and disk diffusion methods for differentiating daptomycin-susceptible from non-daptomycin-susceptible Staphylococcus aureus isolates. J Clin Microbiol. 2006;44:3098–104.

    PubMed  Article  CAS  Google Scholar 

Download references

Acknowledgments

We thank Cubist Pharmaceuticals, Inc., for kindly providing daptomycin reagent powder for this study.

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hanae Nakashima.

About this article

Cite this article

Nakashima, H., Takahashi, H., Kameko, M. et al. Daptomycin Etest MICs for methicillin-resistant Staphylococcus aureus vary among different media. J Infect Chemother 18, 970–972 (2012). https://doi.org/10.1007/s10156-012-0424-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10156-012-0424-5

Keywords

  • Methicillin-resistant Staphylococcus aureus (MRSA)
  • Daptomycin
  • MIC
  • Ca2+ concentration
  • Broth microdilution
  • Etest